Sandra Levy
ARTICLES BY THIS AUTHOR
- 11/13/2022
Viatris wins court decision invalidating AstraZeneca's Symbicort patent
The district court determined that the patent is invalid on two separate grounds – lack of written description and lack of enablement, the company said. - 11/13/2022
Walgreens, VillageMD expand to Las Vegas
VillageMD and Walgreens now have more than 150 Village Medical at Walgreens locations in markets across the country – including in Arizona, Florida, Texas, Kentucky, Indiana, Massachusetts, New Hampshire, Georgia and Rhode Island, in addition to Nevada. - 11/10/2022
Lannett, Ypsomed AG ink deal on pen injector device
Lannett and HEC will, in exchange for its financial contribution, receive a sub-license to a licensing arrangement between Ypsomed and Sanofi-Aventis Deutschland GmbH. - 11/10/2022
Southeastern Grocers offering affordable Thanksgiving feasts
The grocer is offering deals on Thanksgiving turkeys, hams and other holiday essentials ahead of the holidays. - 11/10/2022
Walgreens Boots Alliance strengthens commitment to expand disability representation
WBA is redesigning its annual bonus plan in the United States to include a disability representation metric. - 11/9/2022
Sun Pharma, SPARC ink deal for commercialization of phenobarbital for injection
The product, which is awaiting FDA approval, is targeted at treating seizures in neonatal patients. - 11/9/2022
Eatwell Market by Schnucks to debut in Chesterfield, Mo.
The Boone’s Crossing store, which is expected to open in Spring 2023 is the second store to operate under the Eatwell Market banner. - 11/9/2022
Target stores get a makeover
Target's new store layout, built and tested using virtual reality, is bigger than its previous stores. - 11/9/2022
Cardinal Health's Outcomes platform chosen by Transaction Data Systems
TDS is adding the Outcomes digital ecosystem to its portfolio of pharmacy solutions. - 11/8/2022
Local brands’ value proposition buoy Ahold Delhaize’s Q3 sales, earnings
Comparable store sales excluding gas increased 7.9% in Q3, with an acceleration in growth rates in both the United States and Europe to 8.2% and 7.4%, respectively.
